Biostage Announces Publication Showing Rapid Esophageal Regeneration in Pigs

Harvard Apparatus Regenerative Technology, Inc.

Publication in Journal of Immunology and Regenerative Medicine describes regeneration after Biostage Esophageal Implant in nine pigs with full circumferential replacement.
All animals regenerated a continuous biological conduit by 28 days; some as early as 14 days.
Regeneration time compares favorably with FDA-approved clinical trial primary endpoint of 90 days.
Biostage expects to initiate patient recruitment in first clinical trial in early 2023.
Study also quantified epithelialization and fate of adipose-derived mesenchymal stromal cells.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.